Clinical Rheumatology

, Volume 27, Issue 9, pp 1195–1197

Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?

  • Eishi Miyazaki
  • Masaru Ando
  • Tetsujiro Fukami
  • Shin-ichi Nureki
  • Yoshinobu Eishi
  • Toshihide Kumamoto
Case Report

Abstract

A 47-year-old female was diagnosed to have pulmonary, ocular, and nodular-type muscular sarcoidosis. Seven years later, nodules developed in all limb muscles. She received minocycline 200 mg daily, which resulted in an obvious reduction of the muscular sarcoidosis with a significant decrease in the serum angiotensin-converting enzyme level. Nine months later, the minocycline was discontinued, thus resulting in a rapid recurrence of the disease. The immediate readministration of minocycline again resulted in a prompt improvement. We detected Propionibacterium acnes within the granulomas in the affected muscle by an immunohistochemistry. More interestingly, we found a decrease in the circulating levels of interleukin-12 p40 and interferon-inducible protein-10 during the minocycline therapy. The minocycline therapy may be effective for sarcoidosis and the fact that the disease rapidly relapsed after discontinuation of the minocycline administration suggests that the mechanism of action in this case may be immunomodulating but not antimicrobial effect.

Keywords

Chemokine Minocycline Propionibacterium acnes Sarcoidosis Treatment 

References

  1. 1.
    Bachelez H, Senet P, Candranel J et al (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69–73PubMedGoogle Scholar
  2. 2.
    Park DJJ, Woog JJ, Pulido JS et al (2007) Minocycline for the treatment of ocular and ocular adnexal sarcoidosis. Arch Ophthalmol 125:705–709PubMedCrossRefGoogle Scholar
  3. 3.
    Ishige I, Usui Y, Takemura T et al (1999) Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354:120–123PubMedCrossRefGoogle Scholar
  4. 4.
    Webster GF, Toso SM, Hegemann L (1994) Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Arch Dermatol 130:748–752PubMedCrossRefGoogle Scholar
  5. 5.
    Thong YH, Ferrante A (1979) Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogue. Clin Exp Immunol 35:443–446PubMedGoogle Scholar
  6. 6.
    Kremlev SG, Roberts RL, Palmer C (2004) Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 149:1–9PubMedCrossRefGoogle Scholar
  7. 7.
    Agostini C, Cassatella M, Zambello R et al (1998) Involvement of the IP-10 chemokine in sarcoid granulomatous reaction. J Immunol 161:6413–6420PubMedGoogle Scholar
  8. 8.
    Hata M, Sugisaki K, Miyazaki E et al (2007) Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical marker. Intern Med 46:1387–1393PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2008

Authors and Affiliations

  • Eishi Miyazaki
    • 1
  • Masaru Ando
    • 1
  • Tetsujiro Fukami
    • 1
  • Shin-ichi Nureki
    • 1
  • Yoshinobu Eishi
    • 3
  • Toshihide Kumamoto
    • 2
  1. 1.Division of Pulmonary Disease, Department of Brain and Nerve ScienceOita University Faculty of MedicineOitaJapan
  2. 2.Division of Neurology and Neuromuscular Disorders, Department of Brain and Nerve ScienceOita University Faculty of MedicineOitaJapan
  3. 3.Department of PathologyTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations